Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Applied Lipid Technologies
Entity

Applied Lipid Technologies

Tracked across 2 events · 14 articles · First seen Apr 11, 2026 · Last active Aug 20, 2026

Sentiment
18
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 20
Business
Lobe Sciences Ltd. Closes Private Placement
Impact: Applied Lipid Technologies, a wholly owned subsidiary of Lobe Sciences, will receive a portion of the private placement proceeds to support the development of the S-100 program toward human clinical trials.
Apr 11, 2026 · 7 articles
1 15
Business
Lobe Sciences Private Placement Closing
Lobe Sciences, a clinical-stage biopharmaceutical company, announced and closed a non-brokered private placement of 24,705,880 common shares at $0.085 per share, raising approximately $2.1 million. The proceeds will be used for working capital, general corporate…
Impact: Applied Lipid Technologies, a wholly owned subsidiary, will receive a portion of the proceeds to advance the S-100 program toward human clinical trials. The funding supports its lead asset for sickle cell disease.
Aug 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Applied Lipid Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.